Steven Gallinger

68.4k total citations · 6 hit papers
354 papers, 25.6k citations indexed

About

Steven Gallinger is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Steven Gallinger has authored 354 papers receiving a total of 25.6k indexed citations (citations by other indexed papers that have themselves been cited), including 226 papers in Oncology, 146 papers in Pathology and Forensic Medicine and 108 papers in Cancer Research. Recurrent topics in Steven Gallinger's work include Genetic factors in colorectal cancer (137 papers), Pancreatic and Hepatic Oncology Research (114 papers) and Cancer Genomics and Diagnostics (94 papers). Steven Gallinger is often cited by papers focused on Genetic factors in colorectal cancer (137 papers), Pancreatic and Hepatic Oncology Research (114 papers) and Cancer Genomics and Diagnostics (94 papers). Steven Gallinger collaborates with scholars based in Canada, United States and Australia. Steven Gallinger's co-authors include Aaron Pollett, Catherine O′Brien, John E. Dick, Mark Redston, Malcolm J. Moore, Stephen N. Thibodeau, Robert Gryfe, Bharati Bapat, Paul D. Greig and Melyssa Aronson and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Steven Gallinger

344 papers receiving 25.0k citations

Hit Papers

A human colon cancer cell capable of initiating tumour gr... 2000 2026 2008 2017 2006 2007 2003 2010 2000 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
    2006 3.3k citations Catherine O′Brien, Aaron Pollett et al. profile →
  2. Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
    2007 2.9k citations Steven Gallinger et al. Journal of Clinical Oncology profile →
  3. Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
    2003 1.6k citations Christine Ribic, Daniel J. Sargent et al. profile →
  4. Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
    2010 1.1k citations Daniel J. Sargent, Silvia Marsoni et al. Journal of Clinical Oncology profile →
  5. Tumor Microsatellite Instability and Clinical Outcome in Young Patients with Colorectal Cancer
    2000 1.1k citations Steven Gallinger et al. profile →
  6. Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer
    2012 557 citations Antonija Kreso, Catherine O′Brien et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven Gallinger Canada 69 16.8k 8.6k 7.1k 7.0k 4.4k 354 25.6k
Heinz‐Josef Lenz United States 83 24.6k 1.5× 8.2k 1.0× 9.7k 1.4× 6.4k 0.9× 5.4k 1.2× 860 35.9k
Gloria M. Petersen United States 79 14.3k 0.9× 9.2k 1.1× 7.9k 1.1× 6.9k 1.0× 5.0k 1.1× 268 24.8k
Salvatore Siena Italy 76 26.8k 1.6× 8.5k 1.0× 7.6k 1.1× 7.0k 1.0× 4.7k 1.1× 534 37.8k
Scott Kopetz United States 84 20.5k 1.2× 7.6k 0.9× 7.3k 1.0× 7.6k 1.1× 5.0k 1.1× 676 29.0k
Jeffrey S. Ross United States 81 15.0k 0.9× 4.2k 0.5× 10.3k 1.5× 9.1k 1.3× 4.0k 0.9× 680 28.7k
J. Milburn Jessup United States 53 11.9k 0.7× 3.7k 0.4× 6.2k 0.9× 4.0k 0.6× 4.3k 1.0× 144 20.7k
Howard A. Burris United States 89 25.4k 1.5× 3.8k 0.4× 13.0k 1.8× 6.2k 0.9× 4.2k 1.0× 741 38.2k
Anthony T.�C. Chan Hong Kong 86 11.7k 0.7× 2.4k 0.3× 7.8k 1.1× 6.1k 0.9× 7.2k 1.6× 456 27.6k
David S. Hong United States 77 10.4k 0.6× 2.7k 0.3× 9.5k 1.3× 5.8k 0.8× 2.1k 0.5× 817 23.2k
Marco A. Pierotti Italy 85 10.7k 0.6× 3.9k 0.5× 13.3k 1.9× 5.5k 0.8× 2.6k 0.6× 457 27.2k

Countries citing papers authored by Steven Gallinger

Since Specialization
Citations

This map shows the geographic impact of Steven Gallinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Gallinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Gallinger more than expected).

Fields of papers citing papers by Steven Gallinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Gallinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Gallinger. The network helps show where Steven Gallinger may publish in the future.

Co-authorship network of co-authors of Steven Gallinger

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Gallinger. A scholar is included among the top collaborators of Steven Gallinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Gallinger. Steven Gallinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomas, Claire E., Yasutoshi Takashima, Daniel D. Buchanan, et al.. (2025). Density of T-cell Subsets in Colorectal Cancer in Relation to Disease-Specific Survival. Cancer Epidemiology Biomarkers & Prevention. 34(7). 1122–1133. 1 indexed citations
2.
Liu, Ning, Nathan Taback, Steven Gallinger, et al.. (2024). Machine Learning to Allocate Palliative Care Consultations During Cancer Treatment. Journal of Clinical Oncology. 42(14). 1625–1634. 7 indexed citations
3.
4.
Knox, Jennifer J., Elizabeth M. Jaffee, Grainne M. O’Kane, et al.. (2024). Early results of the PASS-01 trial: Pancreatic adenocarcinoma signature stratification for treatment-01.. Journal of Clinical Oncology. 42(17_suppl). LBA4004–LBA4004. 6 indexed citations
5.
Ubhi, Tajinder, Olga Zaslaver, Andrew T. Quaile, et al.. (2024). Cytidine deaminases APOBEC3C and APOBEC3D promote DNA replication stress resistance in pancreatic cancer cells. Nature Cancer. 5(6). 895–915. 12 indexed citations
6.
Komosa, Martin, Sumedha Sudhaman, Ricardo Leão, et al.. (2021). Dual role of allele-specific DNA hypermethylation within the TERT promoter in cancer. Journal of Clinical Investigation. 131(21). 1570–1575. 18 indexed citations
7.
Zheng, Yingye, Xinwei Hua, Aung Ko Win, et al.. (2020). A New Comprehensive Colorectal Cancer Risk Prediction Model Incorporating Family History, Personal Characteristics, and Environmental Factors. Cancer Epidemiology Biomarkers & Prevention. 29(3). 549–557. 25 indexed citations
8.
Lo, Christopher, Shari Moura, Sarah Buchanan, et al.. (2019). Development of a psychoeducational intervention for people affected by pancreatic cancer. Pilot and Feasibility Studies. 5(1). 80–80. 5 indexed citations
9.
Wang, Xiaoliang, Andrew T. Chan, Martha L. Slattery, et al.. (2018). Influence of Smoking, Body Mass Index, and Other Factors on the Preventive Effect of Nonsteroidal Anti-Inflammatory Drugs on Colorectal Cancer Risk. Cancer Research. 78(16). 4790–4799. 26 indexed citations
10.
Gorgen, Andre, Hala Muaddi, Wei Zhang, et al.. (2018). The New Era of Transplant Oncology: Liver Transplantation for Nonresectable Colorectal Cancer Liver Metastases. Canadian Journal of Gastroenterology and Hepatology. 2018. 1–7. 37 indexed citations
11.
O’Kane, Grainne M., Ashton A. Connor, & Steven Gallinger. (2017). Characterization, Detection, and Treatment Approaches for Homologous Recombination Deficiency in Cancer. Trends in Molecular Medicine. 23(12). 1121–1137. 42 indexed citations
12.
Childs, Erica J., Kari G. Chaffee, Steven Gallinger, et al.. (2016). Association of Common Susceptibility Variants of Pancreatic Cancer in Higher-Risk Patients: A PACGENE Study. Cancer Epidemiology Biomarkers & Prevention. 25(7). 1185–1191. 22 indexed citations
13.
McWilliams, Robert R., Patrick Maisonneuve, William R. Bamlet, et al.. (2015). Risk Factors for Early-Onset and Very-Early-Onset Pancreatic Adenocarcinoma. Pancreas. 45(2). 311–316. 93 indexed citations
14.
Anderson, Laura N., Michelle Cotterchio, Julia A. Knight, et al.. (2013). Genetic Variants in Vitamin D Pathway Genes and Risk of Pancreas Cancer; Results from a Population-Based Case-Control Study in Ontario, Canada. PLoS ONE. 8(6). e66768–e66768. 40 indexed citations
15.
Kreso, Antonija, Catherine O′Brien, Peter van Galen, et al.. (2012). Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer. Science. 339(6119). 543–548. 557 indexed citations breakdown →
16.
Win, Aung Ko, James G. Dowty, Yoland Antill, et al.. (2011). Body Mass Index in Early Adulthood and Endometrial Cancer Risk for Mismatch Repair Gene Mutation Carriers. Obstetrics and Gynecology. 117(4). 899–905. 14 indexed citations
17.
Cicek, Mine, Noralane M. Lindor, Steven Gallinger, et al.. (2011). Quality Assessment and Correlation of Microsatellite Instability and Immunohistochemical Markers among Population- and Clinic-Based Colorectal Tumors. Journal of Molecular Diagnostics. 13(3). 271–281. 113 indexed citations
18.
Rumilla, Kandelaria M., Noralane M. Lindor, Brittany C. Thomas, et al.. (2011). Frequency of Deletions of EPCAM (TACSTD1) in MSH2-Associated Lynch Syndrome Cases. Journal of Molecular Diagnostics. 13(1). 93–99. 58 indexed citations
19.
Sargent, Daniel J., Silvia Marsoni, Geneviève Monges, et al.. (2010). Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer. Journal of Clinical Oncology. 28(20). 3219–3226. 1114 indexed citations breakdown →
20.
Labbé, Étienne, Lisa Lock, Ainhoa Letamendı́a, et al.. (2007). Transcriptional Cooperation between the Transforming Growth Factor-β and Wnt Pathways in Mammary and Intestinal Tumorigenesis. Cancer Research. 67(1). 75–84. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heinz‐Josef Lenz Breakdown of academic impact, for papers by Gloria M. Petersen Breakdown of academic impact, for papers by Salvatore Siena Breakdown of academic impact, for papers by Scott Kopetz Breakdown of academic impact, for papers by Jeffrey S. Ross Breakdown of academic impact, for papers by J. Milburn Jessup Breakdown of academic impact, for papers by Howard A. Burris Breakdown of academic impact, for papers by Anthony T.�C. Chan Breakdown of academic impact, for papers by David S. Hong Breakdown of academic impact, for papers by Marco A. Pierotti
Rankless by CCL
2026